EP2661261
Ónæmisbælandi samsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.1.2012EP published:
31.7.2019EP application number:
12700262.4
EP translation filed:
29.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
4.1.2032Expiry date:
4.1.2027Next due date:
31.1.2027
Title:
IMMUNOSUPPRESSANT FORMULATIONS
Timeline
Today
5.1.2012EP application
31.7.2019EP Publication
29.10.2019Translation submitted
15.11.2019Registration published
4.1.2027Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BOUILLOT, PhilippeAddress:
Basel, CH
Name:
REYNAUD, EmericAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
11150431Date:
7.1.2011Country:
EP
Classification
Categories:
A61K 9/20, A61K 31/397
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 31.12.2019
Expires: 4.1.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.12.2020
Expires: 4.1.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 28.12.2021
Expires: 4.1.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 22.12.2022
Expires: 4.1.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 27.12.2023
Expires: 4.1.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.1.2025
Expires: 4.1.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 13.1.2026
Expires: 4.1.2027
Payer: Árnason Faktor ehf.